We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aegerion Pharmaceuticals, Inc. | NASDAQ:AEGR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.97 | 1.91 | 1.97 | 0 | 01:00:00 |
Title of Class
|
Amount
|
|
Convertible Senior Notes due 2025
|
$125 million aggregate principal amount
|
Applicant
|
Form of Organization
|
Jurisdiction of Organization
|
||
Corporation
|
Delaware
|
|||
Aegerion Pharmaceuticals Holdings, Inc.
|
Corporation
|
Delaware
|
||
Aegerion Securities Corporation
|
Corporation
|
Massachusetts
|
||
Aegerion Pharmaceuticals Ltd.
|
Limited Company
|
Bermuda
|
||
Aegerion Pharmaceuticals Limited
|
Limited Company
|
England/Wales
|
||
Aegerion International Ltd.
|
Limited Company
|
Bermuda
|
||
Aegerion Pharmaceuticals SARL
|
Limited Liability Company
|
Switzerland
|
||
Aegerion Pharmaceuticals K.K.
|
Stock Corporation
|
Japan
|
||
Aegerion Pharmaceuticals, SAS
|
Limited Liability Company
|
France
|
||
Aegerion Pharmaceuticals (Canada) Ltd.
|
Limited Company
|
Canada
|
||
Aegerion Pharmaceuticals Spain, S.L.
|
Limited Liability Company
|
Spain
|
||
Aegerion Pharmaceuticals GmbH
|
Limited Liability Company
|
Germany
|
||
Aegerion Brasil Comercio e Importacao de Medicamentos LTDA
|
Limited Liability Company
|
Brazil
|
||
Aegerion Pharmaceuticals S.r.l.
|
Limited Liability Company
|
Italy
|
||
(the above named entities are the “Aegerion Entities”)
|
||||
Amryt Pharma Holdings Limited (the “Parent”)
|
Limited Company
|
England/Wales
|
||
Amryt Pharma Limited
|
Limited Company
|
England/Wales
|
||
Amryt Pharmaceuticals DAC
|
Designated Activity Company
|
Ireland
|
||
Amryt Research Limited
|
Limited Company
|
Ireland
|
||
Amryt Genetics Limited
|
Limited Company
|
Ireland
|
||
Amryt Lipidology Limited
|
Limited Company | Ireland | ||
Amryt AG (previously Birken AG)
|
Public Limited Company
|
Germany, Mannheim
|
Amryt Pharma Holdings Limited
Amryt Pharma Limited
Amryt Pharmaceuticals DAC
Amryt Research Limited
Amryt Genetics Limited
Amryt Lipidology Limited
Amryt AG (previously Birken AG)
|
|
Name
|
Position
|
Harry Stratford
|
Non-executive Chairman
|
Joseph Wiley
|
Chief Executive Officer
|
Rory Nealon
|
Chief Financial Officer and Chief Operating Officer
|
James Culverwell
|
Non-executive Director
|
Ray Stafford
|
Non-executive Director
|
Markus Zeiner
|
Non-executive Director
|
As of the Effective Date, for all Applicants:
|
|
Name
|
Position
|
Joseph Wiley
|
Chief Executive Officer
|
Ray Stafford
|
Non-executive Director
|
Applicant
|
Title of Equity Securities
|
Amount Authorized
|
Amount Outstanding
|
|||
Aegerion Pharmaceuticals, Inc.
|
Common Stock, par value $0.01 per share
|
1,000 shares
|
1,000 shares
|
|||
Aegerion Pharmaceuticals Holdings, Inc.
|
Common Stock, par value $0.01 per share
|
100 shares
|
100 shares
|
|||
Aegerion Securities Corporation
|
Common Stock, par value $0.01 per share
|
1,000 shares
|
100 shares
|
|||
Aegerion Pharmaceuticals Ltd.
|
Ordinary Shares, par value $1.00 per share
|
10,000 shares
|
10,000 shares
|
|||
Aegerion Pharmaceuticals Limited
|
Ordinary Shares, par value £1.00 per share
|
3 shares
|
3 shares
|
|||
Aegerion International Ltd.
|
Ordinary Shares, par value $1.00 per share
|
1,000 shares
|
1,000 shares
|
|||
Aegerion Pharmaceuticals SARL
|
Ordinary Shares, par value 100 CHF per share
|
200 shares
|
200 shares
|
|||
Aegerion Pharmaceuticals K.K.
|
Ordinary Shares, par value 10,000 JPY per share
|
1,000 shares
|
10 shares
|
|||
Aegerion Pharmaceuticals, SAS
|
Ordinary Shares, par value €1.00 per share
|
30,000 shares
|
30,000 shares
|
|||
Aegerion Pharmaceuticals (Canada) Ltd.
|
Common Shares, no par value
|
100 shares
|
100 shares
|
|||
Aegerion Pharmaceuticals Spain, S.L.
|
Ordinary Shares, par value €1.00 per share
|
25,000 shares
|
25,000 shares
|
|||
Aegerion Pharmaceuticals GmbH
|
Ordinary Shares, par value €1.00 per share
|
25,000 shares
|
25,000 shares
|
|||
Aegerion Brasil Comercio e Importacao de Medicamentos LTDA
|
Ordinary Shares, par value 3 BRL per share
|
300 shares
|
300 shares
|
|||
Aegerion Pharmaceuticals S.r.l.
|
Ordinary Shares, par value €1.00 per share
|
10,000 shares
|
10,000 shares
|
|||
Amryt Pharma Holdings Limited
|
Ordinary Shares, par value £0.06 per share
|
Unlimited
|
1 share
|
|||
Amryt Pharma Limited
|
Ordinary Shares, par value £0.06 per share
|
Unlimited
|
45,802,881 shares
|
|||
Amryt Pharmaceuticals DAC
|
Ordinary Shares, par value €0.001 per share
|
10,000,000 shares
|
998,630 shares
|
|||
B Ordinary Shares, par value €0.001 per share
|
100,000 shares
|
56,775 shares
|
||||
Amryt Research Limited
|
Ordinary Shares, par value €1.00 per share
|
1,000,000 shares
|
100 shares
|
|||
Amryt Genetics Limited
|
Ordinary Shares, par value €1.00 per share
|
1,000,000 shares
|
100 shares
|
|||
Amryt Lipidology Limited | Ordinary Shares, par value €1.00 per share | 1,000,000 shares | 100 shares | |||
Amryt AG (previously Birken AG)
|
Ordinary Shares, no par value
|
21,205,250 shares
|
21,205,250 shares
|
Certificate of Incorporation of Aegerion Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 of the Form 8-K filed by Aegerion Pharmaceuticals, Inc. (File No. 001-34921) on November 29, 2016.
|
|
Certificate of Incorporation of Aegerion Pharmaceuticals Holdings, Inc.
|
|
Articles of Organization of Aegerion Securities Corporation
|
|
Certificate of Incorporation of Aegerion Pharmaceuticals Ltd.
|
|
Certificate of Incorporation of Aegerion Pharmaceuticals Limited
|
|
Certificate of Incorporation of Aegerion International Ltd.
|
|
The Articles of Association, filed under T3.B7, contains the equivalent of both the charter and the bylaws of Aegerion Pharmaceuticals SARL
|
|
Articles of Incorporation of Aegerion Pharmaceuticals K.K.
|
|
Main Registration Extract from the Trade and Society Register for Aegerion Pharmaceuticals, SAS
|
|
Certificate of Incorporation of Aegerion Pharmaceuticals (Canada) Ltd., Inc.
|
|
Constitution of Aegerion Pharmaceuticals Spain, S.L.
|
|
Commercial Register of Aegerion Pharmaceuticals GmbH
|
|
Social Contract of Aegerion Brasil Comercio e Importacao de Medicamentos Ltda
|
|
Business Register of Aegerion Pharmaceuticals S.r.l.
|
|
Certificate of Incorporation of a Private Limited Company of Amryt Pharma Holdings Limited, a company registered in England and Wales
|
|
Certificate of Incorporation of a Public Limited Company of Amryt Pharma Limited (previously known as Elm Partners PLC), a company registered in England and Wales
|
|
Certificate of Incorporation of Amryt Pharmaceuticals DAC, a company registered in Ireland
|
|
Certificate of Incorporation of Amryt Research Limited, a company registered in Ireland
|
|
Certificate of Incorporation of Amryt Genetics Limited, a company registered in Ireland
|
|
Exhibit T3.A20 |
Certificate of Incorporation of Amryt Lipidology Limited
|
Certificate of Incorporation of Amryt AG
|
|
Bylaws of Aegerion Pharmaceuticals, Inc.
|
|
Bylaws of Aegerion Pharmaceuticals Holdings, Inc.
|
|
Bylaws of Aegerion Securities Corporation
|
|
Bye-laws of Aegerion Pharmaceuticals Ltd.
|
|
Articles of Association of Aegerion Pharmaceuticals Limited
|
|
Bye-laws of Aegerion International Ltd.
|
|
Articles of Association of Aegerion Pharmaceuticals SARL
|
|
Bylaws of Aegerion Pharmaceuticals K.K.
|
|
Constitution of Aegerion Pharmaceuticals, SAS
|
|
Notice of Articles of Aegerion Pharmaceuticals (Canada) Ltd., Inc.
|
|
Bylaws of Aegerion Pharmaceuticals Spain, S.L.
|
|
Articles of Association of Aegerion Pharmaceuticals GmbH
|
|
Bylaws of Aegerion Brasil Comercio e Importacao de Medicamentos Ltda
|
|
Bylaws of Aegerion Pharmaceuticals S.r.l.
|
|
Articles of Association of Amryt Pharma Holdings Limited, a company registered in England and Wales
|
|
Articles of Association of Amryt Pharma Limited, a company registered in England and Wales
|
|
Constitution of Amryt Pharmaceuticals DAC, a company registered in Ireland
|
|
Constitution of Amryt Research Limited, a company registered in Ireland
|
|
Constitution of Amryt Genetics Limited, a company registered in Ireland
|
|
Exhibit T3.B20 |
Constitution of Amryt Lipidology Limited, a company registered in Ireland
|
Translated Articles of Amryt AG
|
|
Exhibit T3D.1
|
Not Applicable.
|
Exhibit T3E.1 |
First Amended Joint Chapter 11 Plan of Reorganization of Aegerion Pharmaceuticals, Inc., filed on July 9, 2019 (incorporated by reference to Exhibit 10.1 of the Form 8-K filed by Novelion Therapeutics Inc. (File No. 000-17082) on July
15, 2019).*
|
Amended Disclosure Statement relating to the Plan of Reorganization of Aegerion Pharmaceuticals, Inc., a Delaware corporation, filed on July 9, 2019 (incorporated by reference to Exhibit 10.2 of the Form 8-K filed by Novelion Therapeutics Inc. (File No. 000-17082) on July 15, 2019).* | |
Exhibit T3E.3 |
Order Approving the Disclosure Statement, dated July 11, 2019 (incorporated by reference to Exhibit 10.3 of the Form 8-K filed by Novelion Therapeutics Inc. (File No. 000-17082) on July 15, 2019).*
|
Cross-reference sheet showing the location in the Indenture of the provisions inserted therein pursuant to Section 310 through 318(a), inclusive, of the Trust Indenture Act of 1939 (included in Exhibit T3C.1 hereto).*
|
|
*Filed previously.
|
AEGERION PHARMACEUTICALS HOLDINGS, INC.
|
||
By:
|
/s/ Benjamin Harshbarger
|
|
Name:
|
Benjamin Harshbarger
|
|
Title:
|
President & Secretary
|
Attest:
|
||
/s/ Barbara Chan
|
||
Name:
|
Barbara Chan
|
AEGERION PHARMACEUTICALS (CANADA) LTD., INC.
AEGERION PHARMACEUTICALS K.K.
|
||
By:
|
/s/ Carolina Alarco
|
|
Name:
|
Carolina Alarco
|
|
Title:
|
Director
|
Attest:
|
||
/s/ Barbara Chan
|
||
Name:
|
Barbara Chan
|
AEGERION BRASIL COMERCIO E IMPORTACAO DE MEDICAMENTOS LTDA
|
||
By:
|
/s/ Luiz Azevedo
|
|
Name:
|
Luiz Azevedo
|
|
Title:
|
General Manager
|
Attest:
|
||
/s/ Edes Balhes
|
||
Name:
|
Edes Balhes
|
AEGERION PHARMACEUTICALS, INC.
AEGERION SECURITIES CORPORATION
AEGERION PHARMACEUTICALS LIMITED
AEGERION PHARMACEUTICALS LTD.
AEGERION PHARMACEUTICALS SARL
AEGERION PHARMACEUTICALS, SAS
AEGERION INTERNATIONAL LTD.
AEGERION PHARMACEUTICALS SPAIN, S.L.
AEGERION PHARMACEUTICALS GMBH
AEGERION PHARMACEUTICALS S.R.L.
|
||
By:
|
/s/ Barbara Chan
|
|
Name:
|
Barbara Chan
|
|
Title:
|
Director
|
Attest:
|
||
/s/ Benjamin Harshbarger
|
||
Name:
|
Benjamin Harshbarger
|
AMRYT PHARMA LIMITED
AMRYT PHARMA HOLDINGS LIMITED
AMRYT PHARMACEUTICALS DAC
AMRYT RESEARCH LIMITED
AMRYT GENETICS LIMITED
AMRYT LIPIDOLOGY LIMITED
AMRYT AG
|
||
By:
|
/s/ Rory Nealon
|
|
Name:
|
Rory Nealon
|
|
Title:
|
Director
|
Attest:
|
||
/s/ John McEvoy
|
||
Name:
|
John McEvoy
|
|
Title:
|
General Counsel
|
1 Year Aegerion Pharmaceuticals, Inc. Chart |
1 Month Aegerion Pharmaceuticals, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions